| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G
| Rho Ventures V, L.P. reports a 5.7% stake in NGM Biopharmaceuticals, Inc. |
| 02/09/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/01/2017 |
SC 13G/A
| Rho Ventures V, L.P. reports a 0% stake in ReachLocal, Inc. |
| 01/06/2015 |
4
| Rho Ventures V, L.P. (10% Owner) has filed a Form 4 on NephroGenex, Inc. |
| 02/19/2014 |
4
| Rho Ventures V, L.P. (10% Owner) has filed a Form 4 on NephroGenex, Inc. |
| 11/30/2012 |
4
| Rho Ventures V, L.P. (10% Owner) has filed a Form 4 on ReachLocal Inc |
| 08/08/2012 |
4
| Rho Ventures V, L.P. (10% Owner) has filed a Form 4 on ReachLocal Inc |
| 02/11/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 05/25/2010 |
4
| Rho Ventures V, L.P. (10% Owner) has filed a Form 4 on ReachLocal Inc |
| 05/19/2010 |
3
| Rho Ventures V, L.P. (10% Owner) has filed a Form 3 on ReachLocal Inc |
| 07/08/2008 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 04/30/2007 |
SC 13D
| Rho Ventures V, L.P. has filed a Schedule 13D for Advancis Pharmaceutical Corporation |
| 04/16/2007 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/14/2007 |
SC 13G/A
| Rho Ventures V, L.P. reports a 15.3% stake in Advancis Pharmaceutical Corporation |
| 02/14/2006 |
SC 13G/A
| Rho Ventures V, L.P. reports a 16.2% stake in Advancis Pharmaceutical Corporation |
| 05/09/2005 |
SC 13G
| Rho Ventures V, L.P. reports a 15.7% stake in ADVANCIS PHARMACEUTICAL CORPORATION |